Keyphrases
Phosphatidylinositol 4-phosphate 5-kinase (PIP5K)
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Kinase Inhibition
100%
Liver Kinase B1 (LKB1)
100%
Mechanistic Target of Rapamycin Kinase
100%
Dual Inhibition
14%
Synergistic Effect
14%
Programmed Death-ligand 1 (PD-L1)
14%
NSCLC Cell Lines
14%
Rapamycin Treatment
14%
Cell Growth
7%
Dual Inhibitor
7%
Signaling Pathway
7%
Cell Death
7%
Protein Expression
7%
Tumor Suppressor
7%
Gene Expression Data
7%
Lung Cancer
7%
Cell Polarity
7%
Novel Therapies
7%
Master Regulator
7%
Akt Phosphorylation
7%
B1 Gene
7%
Therapeutic Strategies
7%
Specific Populations
7%
In Vivo Experiment
7%
Putative Drug Targets
7%
Knockout Cells
7%
Cell Metabolism
7%
Molecular Targeted Therapy
7%
Growth Metabolism
7%
In Silico
7%
Signal Analysis
7%
Mutant Cell Line
7%
Serine Threonine Kinase 11
7%
In Silico Experiments
7%
Growth Polarity
7%
Kyoto Encyclopedia of Genes
7%
Medicine and Dentistry
Lung Cancer
100%
Phosphotransferase
100%
Mechanistic Target of Rapamycin
100%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
100%
Non-Small Cell Lung Cancer
35%
Cell Line
28%
Rapamycin
14%
In Silico
14%
In Vitro
7%
Cell Growth
7%
Cell Death
7%
Immunotherapy
7%
Protein Expression
7%
Signal Transduction
7%
Gene Expression
7%
Molecularly Targeted Therapy
7%
Programmed Death 1 Ligand 1
7%
Tumor Suppressor Protein
7%
Cell Mutant
7%
Protein Kinase LKB1
7%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
100%
Lung Cancer
100%
Mammalian Target of Rapamycin
100%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
100%
Rapamycin
14%
Tumor Suppressor Protein
7%
Immunotherapy
7%
Programmed Death 1 Ligand 1
7%
Protein Kinase LKB1
7%